Cilia are minute hair-like structures present on the surface of respiratory mucosa. Each of these cilia beat continuously at 10–18 Hz, and this beating creates a constant flow of periciliary fluid, ...

Cilia are minute hair-like structures on the respiratory mucosa, which beat continuously at 10–18 Hz, and create a constant flow of periciliary fluid maintaining the sterility of the lower respiratory ...

Primary ciliary dyskenisia (PCD) is a rare genetic disease that causes the tiny hair-like filtration structures in the respiratory tract to stop working. As a result, the lungs accumulate thick mucus ...

The researchers' findings, reported in Nature Structural & Molecular Biology, which involve radial spoke 3 (RS3), help answer some fundamental questions about how motile cilia work and could ...

Please provide your email address to receive an email when new articles are posted on . Six months of azithromycin maintenance therapy reduced the rate of respiratory exacerbations and pathogenic ...

Please provide your email address to receive an email when new articles are posted on . Both percent-predicted FEV 1 and FVC in primary ciliary dyskinesia improved with the addition of idrevloride to ...

Mechanical engineers have developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases ...

ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery to power the next wave of mRNA and gene correction therapeutics, today announced the presentation of ...

A coronavirus infection can mow down the forests of hairlike cilia that coat our airways, destroying a crucial barrier to keeping the virus from lodging deep in the lungs. Normally, those cilia move ...

Researchers said understanding the overlap between primary ciliary dyskinesia and asthma is critical to helping young patients have healthier respiratory outcomes. INDIANAPOLIS — Indiana University ...

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...